These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21241732)

  • 1. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.
    Climent N; Munier S; Piqué N; García F; Pavot V; Primard C; Casanova V; Gatell JM; Verrier B; Gallart T
    Vaccine; 2014 Oct; 32(47):6266-76. PubMed ID: 25240755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.
    Van Gulck ER; Vanham G; Heyndrickx L; Coppens S; Vereecken K; Atkinson D; Florence E; Kint I; Berneman ZN; Van Tendeloo V
    J Virol; 2008 Apr; 82(7):3561-73. PubMed ID: 18234800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
    Huang XL; Fan Z; Borowski L; Rinaldo CR
    Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
    Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
    Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
    Climent N; Guerra S; García F; Rovira C; Miralles L; Gómez CE; Piqué N; Gil C; Gatell JM; Esteban M; Gallart T
    PLoS One; 2011; 6(5):e19644. PubMed ID: 21625608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.
    Kulkarni V; Rosati M; Valentin A; Ganneru B; Singh AK; Yan J; Rolland M; Alicea C; Beach RK; Zhang GM; Le Gall S; Broderick KE; Sardesai NY; Heckerman D; Mothe B; Brander C; Weiner DB; Mullins JI; Pavlakis GN; Felber BK
    PLoS One; 2013; 8(3):e60245. PubMed ID: 23555935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
    Kanagavelu SK; Snarsky V; Termini JM; Gupta S; Barzee S; Wright JA; Khan WN; Kornbluth RS; Stone GW
    Vaccine; 2012 Jan; 30(4):691-702. PubMed ID: 22146759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.
    Chege GK; Burgers WA; Stutz H; Meyers AE; Chapman R; Kiravu A; Bunjun R; Shephard EG; Jacobs WR; Rybicki EP; Williamson AL
    J Virol; 2013 May; 87(9):5151-60. PubMed ID: 23449790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A
    Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.
    Ondondo BO; Yang H; Dong T; di Gleria K; Suttill A; Conlon C; Brown D; Williams P; Rowland-Jones SL; Hanke T; McMichael AJ; Dorrell L
    Eur J Immunol; 2006 Oct; 36(10):2585-94. PubMed ID: 17013989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
    Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
    Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
    J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.
    Van Gulck ER; Ponsaerts P; Heyndrickx L; Vereecken K; Moerman F; De Roo A; Colebunders R; Van den Bosch G; Van Bockstaele DR; Van Tendeloo VF; Allard S; Verrier B; Marañón C; Hoeffel G; Hosmalin A; Berneman ZN; Vanham G
    Blood; 2006 Mar; 107(5):1818-27. PubMed ID: 16263796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
    Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.